Indication

Multicentric

1 clinical trial

1 product

Clinical trial

A Phase II, Single-arm Open-label Multi-center Study of Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

Status: Recruiting, Estimated PCD: 2024-06-30

Product